NASDAQ:RNA
Avidity Biosciences, Inc.
- Stock
Last Close
29.51
16/05 20:00
Market Cap
956.16M
Beta: −0.10
Volume Today
1.04M
Avg: 1.32M
PE Ratio
−4.46
PFCF: −4.85
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 0.50 - | ||||||
average payables | 1.94M - | 1.15M 40.41% | 2.32M - | 2.32M 0% | |||
average receivables | 1.05M - | ||||||
book value per share | -1.99 - | -3.16 58.91% | 14.14 547.32% | 9.21 34.87% | 11.08 20.37% | 6.86 38.11% | |
capex per share | -0.00 - | -0.01 379.59% | -0.05 343.64% | -0.09 79.09% | -0.05 40.05% | -0.06 7.00% | |
capex to depreciation | -0.13 - | -0.68 427.83% | -2.93 333.54% | -5.85 99.92% | -2.04 65.23% | 0.46 122.65% | |
capex to operating cash flow | 0.01 - | -0.09 1,959.62% | 0.03 131.17% | 0.04 34.08% | 0.02 47.48% | 0.04 71.41% | |
capex to revenue | -0.13 - | -0.10 21.62% | -0.16 58.77% | -0.40 149.25% | -0.31 23.68% | -0.44 44.51% | |
cash per share | 0.15 - | 4.57 2,960.78% | 15.46 237.98% | 11.84 23.37% | 11.71 1.14% | 8.15 30.36% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 2.59 - | 0.05 98.04% | 0.00 94.49% | 0.03 876.46% | 0.02 39.01% | 0.02 6.31% | |
debt to equity | -0.25 - | -0.08 69.91% | 0.00 104.06% | 0.03 903.88% | 0.02 39.88% | 0.02 6.42% | |
dividend yield | 0.00 - | 0.00 346.60% | |||||
earnings yield | -0.02 - | -0.05 169.16% | -0.08 45.99% | -0.12 49.82% | -0.15 22.56% | -0.32 119.87% | |
enterprise value | 596.67M - | 499.80M 16.24% | 225.64M 54.85% | 589.16M 161.11% | 827.77M 40.50% | 485.53M 41.34% | |
enterprise value over ebitda | -58.99 - | -29.43 50.11% | -5.10 82.68% | -4.99 2.07% | -4.63 7.30% | -2.06 55.46% | |
ev to operating cash flow | -61.80 - | 200.72 424.80% | -6.08 103.03% | -6.21 2.22% | -6.07 2.24% | -4.08 32.87% | |
ev to sales | 1.57K - | 215.52 86.31% | 33.25 84.57% | 63.17 90.02% | 89.74 42.05% | 50.79 43.41% | |
free cash flow per share | -0.47 - | 0.11 123.24% | -1.76 1,717.68% | -2.38 34.87% | -2.67 12.09% | -1.69 36.67% | |
free cash flow yield | -0.02 - | 0.00 123.24% | -0.07 1,906.58% | -0.10 44.80% | -0.12 20.07% | -0.19 55.28% | |
graham net net | -2.03 - | -3.27 61.08% | 14.18 533.23% | 10.73 24.33% | 10.54 1.72% | 6.40 39.27% | |
graham number | 5.08 - | 10.51 106.81% | 25.41 141.82% | 24.23 4.66% | 28.43 17.35% | 21.18 25.50% | |
income quality | 0.86 - | -0.10 111.69% | 0.84 931.24% | 0.80 3.99% | 0.78 2.52% | 0.56 28.36% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -14.62 - | -2.35 83.95% | -211.85 8,929.24% | 31.44 - | |||
interest debt per share | 0.53 - | 0.60 11.61% | 0.05 91.11% | 0.28 434.71% | 0.10 66.16% | 0.13 40.86% | |
inventory turnover | |||||||
invested capital | -0.25 - | -0.08 69.91% | 0.00 104.06% | 0.03 903.88% | 0.02 39.88% | 0.02 6.42% | |
market cap | 589.44M - | 589.44M 0% | 552.84M 6.21% | 984.74M 78.12% | 1.16B 17.54% | 660.76M 42.91% | |
net current asset value | -41.87M - | -66.59M 59.04% | 304.00M 556.54% | 364.99M 20.06% | 562.22M 54.04% | 483.52M 14.00% | |
net debt to ebitda | -0.72 - | 5.28 838.00% | 7.39 40.01% | 3.35 54.66% | 1.84 45.01% | 0.74 59.64% | |
net income per share | -0.58 - | -1.55 169.16% | -2.03 30.73% | -2.83 39.54% | -3.24 14.41% | -2.91 10.33% | |
operating cash flow per share | -0.47 - | 0.12 125.79% | -1.71 1,523.14% | -2.29 33.57% | -2.61 14.15% | -1.63 37.58% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | 22.26 - | 6.27 71.83% | 5.54 11.63% | 10.85 95.83% | 16.31 50.29% | 19.98 22.51% | |
return on tangible assets | -3.00 - | -0.33 88.94% | -0.13 60.26% | -0.27 108.39% | -0.26 3.58% | -0.34 27.56% | |
revenue per share | 0.02 - | 0.11 511.87% | 0.31 179.42% | 0.23 28.15% | 0.18 21.45% | 0.13 25.95% | |
roe | 0.29 - | 0.49 69.38% | -0.14 129.22% | -0.31 114.24% | -0.29 4.95% | -0.42 44.89% | |
roic | 0.36 - | 0.37 3.41% | -0.14 138.00% | -0.29 104.39% | -0.29 0.10% | -0.45 55.27% | |
sales general and administrative to revenue | 6.44 - | 2.20 65.77% | 1.98 10.02% | 2.81 41.61% | 4.09 45.64% | 5.67 38.57% | |
shareholders equity per share | -1.99 - | -3.16 58.91% | 14.14 547.32% | 9.21 34.87% | 11.08 20.37% | 6.86 38.11% | |
stock based compensation to revenue | 0.16 - | 0.18 10.59% | 0.64 262.72% | 1.83 187.99% | 2.94 60.88% | 4.00 35.89% | |
tangible asset value | -41.13M - | -65.36M 58.91% | 306.22M 568.54% | 381.43M 24.56% | 578.08M 51.55% | 500.76M 13.37% | |
tangible book value per share | -1.99 - | -3.16 58.91% | 14.14 547.32% | 9.21 34.87% | 11.08 20.37% | 6.86 38.11% | |
working capital | -1.37M - | 85.44M 6,318.34% | 317.09M 271.13% | 381.48M 20.31% | 571.03M 49.69% | 530.63M 7.08% |
All numbers in USD (except ratios and percentages)